Effect of different SARS-CoV-2 variants on COVID 19 assays and vaccines

June 29, 2021

SARS-CoV-2, the causative agent of COVID-19, has an ssRNA genome of almost 30kb that encodes for a total of 26 proteins. Among the four structural viral protein, in particular the S protein stands out. The S protein protrudes from the spherical virion and gives it its characteristic appearance. It is also crucial for the virus’ interaction with its host cells. Furthermore, the S protein is the main target for most SARS-CoV-2 vaccines. As such, mutations in this protein can severely impact the efficacy of SARS-CoV-2 vaccines.

In this webinar, Dr. Stefan Pellenz Product Manager from Antibodies online and Dr. Andreas Langer, R&D Scientist at NanoTemper Technologies, will review known SARS-CoV-2 S protein mutations, discuss their potential effect on antibody binding, and illustrate this effect on a well characterized anti-S protein antibody.

Learn more about the references mentioned in this webinar.

Previous Video
Improve your protein degrader design with new ways to discover E3 ligase ligands
Improve your protein degrader design with new ways to discover E3 ligase ligands

Targeted protein degradation using molecular glues or proteolysis-targeting chimeras (PROTACs) is an increa...

Up next
Maximize stability & function of SARS-CoV-spike protein and ACE2 receptor using Monolith & Prometheus
Maximize stability & function of SARS-CoV-spike protein and ACE2 receptor using Monolith & Prometheus

Dr. Leah Pandiscia and Dr. Daniel Turman review how to integrate the Prometheus Panta and Monolith instrume...